Extendicare (EXE) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
9 Sep, 2026Strategic growth and market positioning
Largest seniors' care provider in Canada, focused on long-term care (LTC) and home health care, with 58 years of experience and a strong acquisition pipeline in a fragmented market.
Over 90% of revenue is derived from government contracts, providing revenue stability and insulation from economic cycles.
Joint venture with Axium Infrastructure enables capital-efficient LTC growth and managed services expansion.
Technology platform supports high-quality, efficient service delivery and acquisition synergies.
Strong balance sheet with low leverage (2.5x debt to adjusted EBITDA) and $208M available liquidity as of June 30, 2026.
Demographic trends and market demand
Canadian seniors aged 85+ are growing at ~4% per year, with a projected tripling by 2051.
Ontario faces a significant LTC bed shortfall, with the ratio of beds per 1,000 people aged 75+ dropping from 99 in 2006 to 57 in 2024.
Over 200,000 new LTC beds needed in Canada by 2035; Ontario must add 4,000 beds annually to maintain current ratios.
Home health care volume is outpacing seniors' population growth, helping bridge the LTC gap.
Operational performance and segment highlights
Home health care segment delivered 27M hours annually, with adjusted NOI margin at a multi-year high of 13.3% and 80.6% volume growth since 2023.
LTC segment operates 58 fully owned homes with 7,897 beds, maintaining occupancy above 97% and an adjusted NOI margin of 11.8%.
Managed services segment (Assist and SGP) achieved consistent 50-56% NOI margins, serving ~161,700 beds and operating 39 LTC homes.
Latest events from Extendicare
- Q2 2026 Adjusted EBITDA jumped 71.7% to $68.3M, fueled by acquisitions and strong home health growth.EXE
Q2 2026 - Largest seniors' care provider in Canada expands through acquisitions and JV-driven growth.EXE
Investor presentation - Q1 2026 saw 52% EBITDA growth, major acquisitions, and strong Home Healthcare expansion.EXE
Q1 2026 - Financial growth, expanded care, and all proposals approved amid sector and integration challenges.EXE
AGM 2026 - Strong 2025 growth, 5% dividend hike, and $570M CBI Home Health acquisition set for Q2 2026.EXE
Q4 2025 - Double-digit revenue and margin growth, with enhanced liquidity and redevelopment progress.EXE
Q3 2024 - Q2 2024 delivered strong revenue, margin growth, and robust progress in redevelopment.EXE
Q2 2024 - Adjusted EBITDA up 42.7% year-over-year, driven by home health care and managed services growth.EXE
Q1 2025 - Q4 2024 saw strong earnings, margin gains, and a 5% dividend hike, with robust growth across all segments.EXE
Q4 2024